Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin

Kaufmann, C. K.; Ahmed, A. A.; Kassem, M. K.; Freynhofer, M. F.; Jaeger, B. J.; Aicher, G. A.; Equiluz-Bruck, S. E.; Spiel, A. S.; Vafai-Tabrizi, F. V.; Gschwantler, M. G.; Fasching, P. F.; Wojta, J. W.; Giannitsis, E. G.; Huber, K. H.

Kaufmann, C. K.; Ahmed, A. A.; Kassem, M. K.; Freynhofer, M. F.; Jaeger, B. J.; Aicher, G. A.; Equiluz-Bruck, S. E.; Spiel, A. S.; Vafai-Tabrizi, F. V.; Gschwantler, M. G.; Fasching, P. F.; Wojta, J. W.; Giannitsis, E. G.; Huber, K. H..

European Heart Journal ; 42(SUPPL 1):3393, 2021.

Article in English | EMBASE | ID: covidwho-1554244

Keywords

biological, marker; copeptin; endogenous, compound; troponin, I; adult; adverse, outcome; conference,; controlled, study; coronavirus, disease, 2019; deterioration; female; gene, expression; hospital, patient; human; major, clinical, study; male; mortality; observational, study; prediction; prospective, study; protein, expression; receiver, operating, characteristic; tertiary, care, center

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Observational study / Prognostic study Language: English Journal: European Heart Journal Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google